CO52 Modelling Long-Term Outcomes of Tirzepatide Compared to Lifestyle Modification and Other Anti-Obesity Medications As Treatment for Overweight and Obesity
Year: 2023
Type: conference-abstract
Source: Value in Health
Authors: M. Hoog, H. Kan, K. Deger, S. Sorensen, L. Neff, J. Bae, E.R. Hankosky, D. Mojdami, B. White, M. Harris
Institution: Eli Lilly (United States)
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4380150815
